Atossa Therapeutics
ATOS
#10745
Rank
โ‚ฌ18.23 M
Marketcap
1,83ย โ‚ฌ
Share price
2.55%
Change (1 day)
168.93%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): -3,52ย โ‚ฌ

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -3,72ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -3,67ย โ‚ฌ a decrease over its 2024 EPS that were of -2,76ย โ‚ฌ.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-3,52ย โ‚ฌ-4.23%
2025-3,67ย โ‚ฌ32.89%
2024-2,76ย โ‚ฌ-15.56%
2023-3,27ย โ‚ฌ14.29%
2022-2,86ย โ‚ฌ16.67%
2021-2,45ย โ‚ฌ-90.86%
2020-26,86ย โ‚ฌ-2.96%
2019-27,68ย โ‚ฌ-63.09%
2018-75,00ย โ‚ฌ-49.63%
2017-148,91ย โ‚ฌ-57.87%
2016-353,46ย โ‚ฌ-74.01%
2015-1.360ย โ‚ฌ-9.18%
2014-1.497ย โ‚ฌ-12.86%
2013-1.718ย โ‚ฌ70.73%
2012-1.006ย โ‚ฌ34.07%
2011-750,63ย โ‚ฌ263.41%
2010-206,55ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,07ย โ‚ฌ-263.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
9,25ย โ‚ฌ-348.90%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
11,15ย โ‚ฌ-400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-0,23ย โ‚ฌ-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-0,19ย โ‚ฌ-94.87%๐Ÿ‡บ๐Ÿ‡ธ USA